J. A. Staessen, L. Thijs u. a.: Main results of the ouabain and adducin for Specific Intervention on Sodium in Hypertension Trial (OASIS-HT): a randomized placebo-controlled phase-2 dose-finding study of rostafuroxin. In: Trials. Band 12, Januar 2011, S. 13, doi:10.1186/1745-6215-12-13, PMID 21235787, PMC 3031200 (freier Volltext).
futuremedicine.com
Staessen, JA. und Bianchi, G. (2005): Adducin and hypertension. In: Pharmacogenomics6(7); 665–9; PMID 16207143; PDF (freier Volltextzugriff, engl.).
nih.gov
ncbi.nlm.nih.gov
Staessen, JA. und Bianchi, G. (2005): Adducin and hypertension. In: Pharmacogenomics6(7); 665–9; PMID 16207143; PDF (freier Volltextzugriff, engl.).
Manunta, P. (2001): A new antihypertensive agent that antagonizes the prohypertensive effect of endogenous ouabain and adducin. In: Cardiovasc. Hematol. Agents. Med. Chem. Bd. 4, S. 61–66, PMID 16529550.
J. A. Staessen, L. Thijs u. a.: Main results of the ouabain and adducin for Specific Intervention on Sodium in Hypertension Trial (OASIS-HT): a randomized placebo-controlled phase-2 dose-finding study of rostafuroxin. In: Trials. Band 12, Januar 2011, S. 13, doi:10.1186/1745-6215-12-13, PMID 21235787, PMC 3031200 (freier Volltext).